Aaron Geist has joined PerkinElmer as vice president of business development. He will be responsible for developing the firm's partnership and acquisition opportunities, according to the firm. Geist joins PerkinElmer from investment banking firm Robert W. Baird, where he served as director and senior research analyst, covering life science, medical device, and diagnostics firms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.